Exergaming in the treatment of gait, balance, and quality of life in Parkinson's disease: Overview of systematic reviews
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
ROCHA, Poliany Silva
SOUSA, Bianca Brenda Leite de
D'AMELIO, Marco
GARCIA, Patricia Azevedo
LEAL, Josevan Cerqueira
MENDES, Felipe Augusto Dos Santos
Citação
PHYSIOTHERAPY RESEARCH INTERNATIONAL, v.28, n.3, article ID e2002, 13p, 2023
Resumo
Introduction: Postural instability and gait impairments are common in people with PD, both of which have a negative effect on their quality of life. Systematic reviews have demonstrated benefits of using exergaming in enhancing these outcomes. However, there is no consensus over whether exergaming therapy is better than conventional physical therapy for enhancing gait, balance, and quality of life. Objectives: The aim of this overview is to systematically synthesize and evaluate the available evidence found in published systematic reviews and meta-analyses, on the effects of exergaming therapy on balance, gait, and quality of life, compared to conventional physical therapy or no intervention.Methods: This overview was reported in accordance with the statement of Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA). A comprehensive search was carried out in nine databases. Two reviewers independently extracted data using a standardized forms and the search strategy included terms related to intervention, population, and study type. The methodological quality of the included systematic reviews/meta-analysis (SRs/Mas) was evaluated using the ""A Measurement Tool to Assess Systematic Reviews 2"" (AMSTAR-2). The ""Grading of Recommendations Assessment, Development and Evaluation"" (GRADE) was used to assess the quality of the evidence. The risk of bias assessment was performed using the ""Risk Of Bias In Systematic Reviews"" (ROBIS). PROSPERO registration number: CRD42021238131.Results: 112 SRs/MAs were found and nine of them were selected. Six reviews were rated as very low methodological quality and three reviews as low methodological quality. Five reviews were classified with low risk of bias and four reviews with high risk of bias. Most of the SR/MAs demonstrated significant effects on balance favoring exergaming therapy over conventional therapy, however those studies had been rated as very low quality of evidence. Inconclusive results were found for the quality of life and gait outcomes.Conclusion: Exergaming therapy shows promise for the rehabilitation of PD. However, this overview was unable to conclude with certainty that exergaming therapy is superior to conventional physical therapy in improving gait, balance, or quality of life in people with PD. The effectiveness of exergaming therapy in the treatment of people with PD still need to be verified by high-quality studies.
Palavras-chave
balance, exergaming, gait, Parkinson's disease, quality of life
Referências
- Alves MLM, 2018, PERCEPT MOTOR SKILL, V125, P546, DOI 10.1177/0031512518769204
- [Anonymous], 2011, REV BRASILEIRA NEURO
- Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360
- Bacha J. M. R., 2020, KINECT ADVENTURES VE, V33
- Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
- Boonstra TA, 2008, CURR OPIN NEUROL, V21, P461, DOI 10.1097/WCO.0b013e328305bdaf
- Cacabelos R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030551
- Canning CG, 2020, NAT REV NEUROL, V16, P409, DOI 10.1038/s41582-020-0370-2
- Chen Y, 2020, PHYS THER, V100, P933, DOI 10.1093/ptj/pzaa042
- De Souza Dias R., 2009, BRAZILIAN S GAMES DI, V8, P34
- Dockx K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010760.pub2
- Duncan RP, 2011, DISABIL REHABIL, V33, P1440, DOI 10.3109/09638288.2010.533245
- Esculier JF, 2014, J PARKINSON DIS, V4, P67, DOI 10.3233/JPD-130212
- Espy D, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.610095
- Gerling Kathrin, 2014, Gerontechnology, V12, P68, DOI 10.4017/gt.2013.12.2.001.00
- Goncalves GB, 2014, NEUROL INT, V6, P1, DOI [10.4081/ni.2014.5098, 10.4081/ni.2014.5048]
- Herz NB, 2013, PARKINSONISM RELAT D, V19, P1039, DOI 10.1016/j.parkreldis.2013.07.014
- Killane I, 2015, IEEE J BIOMED HEALTH, V19, P1855, DOI 10.1109/JBHI.2015.2479625
- Lei C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224819
- Li RZ, 2021, CLIN REHABIL, V35, P1089, DOI 10.1177/0269215521995179
- Liao YY, 2015, NEUROREHAB NEURAL RE, V29, P658, DOI 10.1177/1545968314562111
- Chen LN, 2020, AM J PHYS MED REHAB, V99, P917, DOI 10.1097/PHM.0000000000001447
- Methley AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0579-0
- Mhatre PV, 2013, PM&R, V5, P769, DOI 10.1016/j.pmrj.2013.05.019
- Mirelman A, 2013, MOVEMENT DISORD, V28, P1597, DOI 10.1002/mds.25670
- Morales-Gomez S, 2018, REV NEUROLOGIA, V66, P69, DOI 10.33588/rn.6603.2017459
- PAGE MJ, 2020, SYST REV-LONDON, V10, P1
- Pieper D, 2014, J CLIN EPIDEMIOL, V67, P368, DOI 10.1016/j.jclinepi.2013.11.007
- Porras DC, 2018, NEUROLOGY, V90, P1017, DOI 10.1212/WNL.0000000000005603
- Prosperini L, 2021, J NEUROL, V268, P3223, DOI 10.1007/s00415-020-09918-w
- Radder DLM, 2020, NEUROREHAB NEURAL RE, V34, P871, DOI 10.1177/1545968320952799
- Santos P, 2019, NEUROREHABILITATION, V44, P569, DOI 10.3233/NRE-192700
- Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979
- Sarac ET, 2022, ACTA NEUROL BELG, V122, P1005, DOI 10.1007/s13760-021-01733-y
- SHEA BJ, 2017, AMSTAR 2 CRITICAL AP, P1
- Triegaardt J, 2020, NEUROL SCI, V41, P529, DOI 10.1007/s10072-019-04144-3
- Wang B, 2019, CLIN REHABIL, V33, P1130, DOI 10.1177/0269215519843174
- Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005
- Zalecki Tomasz, 2013, Folia Med Cracov, V53, P65
- Zeigelboim BS, 2021, INT ARCH OTORHINOLAR, V25, P64, DOI 10.1055/s-0040-1702973